World News: 22:10 GMT Wednesday 13th June 2018. [Novavax, Inc. via Thomson Reuters ONE via SPi World News]
NanoFluTMPhase 12 trial data published in a peer-reviewed letter to the editor inThe New England Journal of Medicine NanoFlu demonstrates significantly improved immune responses against a panel of homologous and drifted AH3N2 influenza viruse...
Thomson Reuters: 22:10 GMT Wednesday 13th June 2018
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 0751938.